Hiroko Ikeda
Papers
1
Total Citations
7
H-Index
1
About
Dr. Hiroko Ikeda is a distinguished urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the refinement of surgical techniques and prognostic indicators. Her work centers on robot-assisted radical prostatectomy (RARP), where she has made significant contributions to understanding the clinical implications of surgical margin status. In her highly cited 2021 study, Dr. Ikeda demonstrated that patients with a Gleason score of 6 at a positive surgical margin experience a biochemical recurrence rate similar to those with negative margins after RARP—a finding that challenges conventional assumptions and helps refine postoperative risk stratification. Her research has garnered over 7 citations, underscoring its impact on clinical practice. By clarifying the nuanced relationship between margin status and disease progression, Dr. Ikeda has provided urologists with valuable insights for patient counseling and treatment planning. Her work continues to shape evidence-based approaches to prostate cancer surgery, offering hope for more personalized and effective management of this prevalent disease.
Research Focus
Key Achievements
Top Papers
- 1